What is the recommended dosing regimen for fexofenadine in adults, adolescents, and children, and how should the dose be adjusted in renal impairment or when taking interacting agents such as antacids, zinc, or iron supplements?

Fexofenadine Dosing Recommendations

For adults and adolescents ≥12 years with seasonal allergic rhinitis or chronic idiopathic urticaria, the recommended dose is 60 mg twice daily or 180 mg once daily; for children 6-11 years, 30 mg twice daily is recommended. 1

Standard Dosing by Indication and Age

Seasonal Allergic Rhinitis

Adults and Children ≥12 years:

• 60 mg twice daily OR 180 mg once daily with water 1
• Both regimens are equally effective 2

Children 6-11 years:

• 30 mg twice daily with water 1, 3

Children 2-5 years:

• 30 mg twice daily (mixed with applesauce for ease of administration) 4

Infants 6 months to 2 years:

• 15 mg or 30 mg twice daily 5
• Safety established for mean treatment duration of 8 days

Chronic Idiopathic Urticaria

Adults and Children ≥12 years:

• 60 mg twice daily OR 180 mg once daily with water 1
• 180 mg once daily effective for up to 6 weeks 2

Children 6-11 years:

• 30 mg twice daily with water 1

Dose Adjustments in Renal Impairment

Fexofenadine requires dose reduction in patients with decreased renal function, as the drug undergoes significant renal elimination. 1

Adults and Children ≥12 years with renal impairment:

• Starting dose: 60 mg once daily (instead of twice daily or 180 mg once daily) 1

Children 6-11 years with renal impairment:

• Starting dose: 30 mg once daily (instead of twice daily) 1

The FDA label specifically recommends these reduced starting doses for patients with decreased renal function, though specific creatinine clearance cutoffs are not provided. This conservative approach prevents drug accumulation in patients with impaired renal clearance.

Drug Interactions Requiring Dose Timing Adjustments

Critical timing consideration: Fexofenadine should NOT be taken with antacids, calcium, iron, magnesium, selenium, or zinc supplements, as these significantly reduce absorption. 6

Specific interacting agents to avoid concurrent administration:

• Dairy products
• Calcium-fortified beverages
• Polyvalent cation-containing laxatives
• Antacids (aluminum/magnesium hydroxide)
• Oral supplements containing calcium, iron, magnesium, selenium, or zinc 6

Practical administration strategy: Separate fexofenadine administration from these agents by at least 2 hours to avoid chelation and reduced bioavailability. Take fexofenadine with water only.

Safety Profile and Clinical Considerations

Fexofenadine demonstrates an excellent safety profile across all age groups studied:

• Non-sedating: Does not cross the blood-brain barrier, showing no dose-related sedation even at doses up to 240 mg/day 7, 2
• No cardiac effects: Does not inhibit cardiac K+ channels or prolong QT interval, even when combined with erythromycin or ketoconazole 2
• Adverse events comparable to placebo: Most common adverse event is headache, occurring at similar rates to placebo 7, 2
• Well-tolerated in special populations: Safe in children as young as 6 months, elderly patients, and those with hepatic impairment 7, 5

Common pitfall to avoid: Do not use first-generation antihistamines (diphenhydramine, chlorpheniramine) as alternatives due to their sedative and cardiovascular effects from poor receptor selectivity. Fexofenadine's high H1-receptor selectivity eliminates these concerns while maintaining efficacy 8.

The onset of symptom relief occurs within ≤2 hours, with sustained 24-hour coverage when dosed once daily at 180 mg or twice daily at 60 mg 2. Fexofenadine effectively addresses both nasal symptoms (sneezing, rhinorrhea, nasal itching) and ocular symptoms (itchy, watery, red eyes) associated with allergic rhinitis 3.